InvestSMART

Invion Limited (ASX: IVX) - Share Price

Current share price for IVX : $0.044 0.001 (2.22%)+

Invion Limited (IVX), an ASX-listed company, is life-science company that is guiding the global research and development of the Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases.

IVX General Information +

ASX Code IVX
Website http://www.inviongroup.com
Industry/Sector Pharmaceuticals
Market Cap ($M) 4
IVX Share Price $0.044
Day High $0.044
Day Low $0.044
Last Close $0.045
IVX Share Price Movement $0.00 ( 2.22% )
Prices as at 12:36, 16 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Invion Limited (IVX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Invion Limited (IVX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Invion Limited (IVX) price-sensitive announcements

IVX - Photosoft Platform Expands to Eye Diseases Via Partnership
Invion Limited has entered into a strategic partnership with SANGMYUNG Innovation Co., Ltd
Invion Limited (IVX)
19 May 2026 | 9:21 AM
IVX - Appendix 4C and Quarterly Activities Report - March 2026
Invion Limited reported key advancements in its Photosoft™ platform for cancer treatment i
Invion Limited (IVX)
30 Apr 2026 | 11:40 AM
IVX - Skin Cancer Trial Moves to BCC With More Encouraging Signals
Invion Limited has announced the expansion of its Non-Melanoma Skin Cancer (NMSC) trial to
Invion Limited (IVX)
21 Apr 2026 | 9:46 AM
IVX - Appendix 4D and Half Year Financial Report
Invion Limited's Appendix 4D and Half Year Financial Report for the period ending 31 Decem
Invion Limited (IVX)
27 Feb 2026 | 9:32 AM

Invion Limited (IVX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Notification regarding unquoted securities - IVX 12 Jun 2026 3:03PM $0.044 $0.044 fallen by 0%
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Notification regarding unquoted securities - IVX 12 Jun 2026 3:01PM $0.044 $0.044 fallen by 0%
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Notification regarding unquoted securities - IVX 12 Jun 2026 2:54PM $0.044 $0.044 fallen by 0%
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Application for quotation of securities - IVX 12 Jun 2026 2:45PM $0.044 $0.044 fallen by 0%
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Results of Extraordinary General Meeting 29 May 2026 5:10PM $0.044 $0.044 fallen by 0%
Invion Limited (IVX)
ORDINARY FULLY PAID
Health Care $4 Photosoft Platform Expands to Eye Diseases Via Partnership 19 May 2026 9:21AM $0.051 $0.044 fallen by 13.73%

IVX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$8.81 -$12.20 39.50% 0.00 0.00 0.00% 0.0%
2024A -$5.63 -$8.80 247.60% 0.00 0.00 0.00% 0.0%
2023A -$1.61 -$2.50 -31.20% 0.00 0.00 0.00% 0.0%

IVX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clarity Pharmaceuticals Ltd (CU6) $802M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Invion Limited (IVX) $4M 0.3950 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $1,691M -0.7857 0.0743 1.2000 57.5419 53.5600 24.3455 0.00% 0.00% 0.00%

IVX Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.46 0.00
Market 0.29 13.20 1.18 0.70
Sector 0.39 27.30 2.56 2.17

IVX Directors

Name Position Start Date
Mr Chiat Thian Chew Chief Executive Officer, Executive Chairman, Executive Director 1 Dec 2017
Mr Alan Yamashita Non-Executive Director 12 Feb 2019
Mr Alistair Bennallack Non-Executive Director 22 Oct 2020
Ms Melanie Jaye Leydin Non-executive director, Company Secretary 31 Aug 2024

Invion Limited (IVX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
23 Jul 2025 CHEW, Chiat Issued Options 10,000,000 $0.015 $150,000.000
18 Jul 2025 BENNALLACK, Alistair Issued Options 181,064 $0.015 $2,715.960
18 Jul 2025 YAMASHITA, Alan Issued Options 115,541 $0.015 $1,733.115

See all changes in directors' interest & trades for Invion Limited (IVX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IVX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Invion Limited (IVX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
11,457,215 (13.38%) Honsue Cho

IVX Calendar of Events

Date Event
26 February 2027 Report (Interim)
26 August 2026 Report (Annual)
26 August 2026 Report (Prelim)
16 June 2026 Issued Shares

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.